Cleared Traditional

K072542 - MAXPLUS TRU-SWAB POSITIVE DISPLACEMENT CONNECTOR

K072542 is an FDA 510(k) clearance for MAXPLUS TRU-SWAB POSITIVE DISPLACEMENT ..., manufactured by Medegen Medical Manufacturing System. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 15-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2007
Decision
15d
Days
Class 2
Risk

K072542 is an FDA 510(k) clearance for the MAXPLUS TRU-SWAB POSITIVE DISPLACEMENT CONNECTOR. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Medegen Medical Manufacturing System (Ontario, US). The FDA issued a Cleared decision on September 25, 2007 after a review of 15 days - a notably fast clearance cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

FDA 510(k) Submission Details - K072542

510(k) Number K072542 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received September 10, 2007
Decision Date September 25, 2007
Days to Decision 15 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Statement
Third-party Review Yes - reviewed by an FDA-accredited third party
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
114d faster than avg
Panel avg: 129d · This submission: 15d
Pathway characteristics
Predicate-based equivalence. No clinical trials required. Third-party reviewed.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Regulatory Technology Services, LLC
MARK JOB

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FPA Set, Administration, Intravascular

All 1099
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K072542.
SURFLO WINGED INFUSION SET WITH NEEDLE PROTECTION (SURSHIELD)
K072894 · Terumo Europe N.V. · Nov 2007
POLYPERF / POLYPERF SAFE
K063631 · Laboratoires Perouse · Oct 2007
PROMEPLA INTRAVASCULAR ADMINISTRATION SET AND EXTENSION SET
K071421 · Promepla · Oct 2007
HEALTH LINE INTERNATIONAL CORPORATION'S PRIMARY IV SOLUTION ADMINISTRATION SET WITH CHECK VALVE
K070630 · Health Line International Corporation (Hlic) · Aug 2007
MODIFICATION TO EZ HUBER SAFETY INFUSION SET
K071846 · Pfm Medical, Inc. · Aug 2007
SURFLO WINGED INFUSION SET WITH FILTER AND NEEDLE PROTECTION (SURSHIELD)
K070547 · Terumo Europe N.V. · May 2007

FDA 510(k) Resources - General Hospital